Up regulation of PD-L1 on peripheral blood CD3+T cells predicts poor prognosis in patients with non-small cell lung cancer (NSCLC) treated with epidermal growth factor receptor (EGFR) inhibitors

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

1 Citation (Web of Science)
Original languageEnglish
Article numberS47
Pages (from-to)S47-S47
Number of pages1
JournalEuropean Journal of Cancer
Issue numberS3
Publication statusPublished - Sept 2015
EventEuropean Cancer Congress - Vienna, Austria
Duration: 25 Sept 201529 Sept 2015

Cite this